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ABSTRACT: CPG15 (aka neuritin) is an activity-
induced GPI-anchored axonal protein that promotes
dendritic and axonal growth, and accelerates synaptic
maturation in vivo. Here we show that CPG15 is distrib-
uted inside axons and on the axon surface. CPG15 is
trafficked to and from the axonal surface by membrane
depolarization. To assess CPG15 trafficking in vivo,
we expressed an ecliptic pHluorin (EP)-CPG15 fusion
protein in optic tectal explants and in retinal ganglion
cells of intact Xenopus tadpoles. Depolarization
by KCl increased EP-CPG15 fluorescence on axons.
Intraocular kainic acid (KA) injection rapidly increased
cell-surface EP-CPG15 in retinotectal axons, but
coinjection of TTX and KA did not. Consistent with
this, we find that intracellular CPG15 is localized to
vesicles and endosomes in presynaptic terminals
and colocalizes with synaptic vesicle proteins. The
results indicate that the delivery of the neurotrophic
protein CPG15 to the axon surface can be regulated
on a rapid time scale by activity-dependent mecha-
nisms in vivo. ' 2008 Wiley Periodicals, Inc. Develop Neurobiol
68: 744–759, 2008
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INTRODUCTION
The spatial and temporal regulation of mechanisms
controlling neuronal growth and synaptogenesis has a
significant impact on the development of neuronal
circuits. Analysis of the function of the GPI-anchored
protein CPG15 (aka neuritin) indicates that it has neu-
rotrophic actions. cpg15 gene expression in cortex of
adult rats is induced by sensory activity (Nedivi et al.,
1996; Harwell et al., 2005) following activation of
NMDAR, CamKII, and CREB (Fujino et al., 2003),
and in Xenopus tadpoles following increased activity
by kainic acid (KA) injection (Javaherian et al.,
1998), however expression during early development
appears to be insensitive to activity blockade (Corri-
veau et al., 1999). Furthermore, visually induced
expression of cpg15 in the cortex of adult rats
depends on visual experience during development
(Lee and Nedivi, 2002), suggesting a complex experi-
ence-dependent regulation of cpg15 gene expression.
CPG15 is also induced in the brain following hypoxia
(Le Jan et al., 2006), neurotrophin treatment (Pahnke
et al., 2004; Lee et al., 2005; Wibrand et al., 2006),
androgen treatment (Marron et al., 2005), or neuronal
injury (Di Giovanni et al., 2005; Tetzlaff et al.,
2006). In addition to the GP1-linked form of CPG15,
a soluble form of CPG15 is expressed during early
development and appears to function as a survival
factor for cortical progenitors (Putz et al., 2005).
CPG15 enhances the development of neuronal
dendritic and axonal arbors in vivo (Nedivi et al.,
1998; Cantallops et al., 2000) and in vitro (Naeve
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et al., 1997), and accelerates the maturation of gluta-
matergic synapses in vivo (Nedivi et al., 1998; Can-
tallops et al., 2000). More recent studies indicate that
CPG15 expression in motor neurons is synaptogenic
and increases axon arbor elaboration at muscle end-
plates (Javaherian and Cline, 2005). In vivo studies
demonstrate that CPG15 must be attached to the
plasma membrane by its GPI anchor to have its neu-
rotrophic effects (Nedivi et al., 1998; Cantallops
et al., 2000). Therefore, the mechanisms that control
cell-surface CPG15 levels essentially control the
function of the GPI-linked form of CPG15. Identifica-
tion of the mechanisms controlling cell-surface levels
of CPG15 is essential to understand the function of
the protein and its role in brain development.
GPI-anchored molecules encompass a large group
of proteins of great functional diversity (Low, 1989;
Field, 1993), including many axon guidance mole-
cules (Walsh and Doherty, 1997). The trafficking
mechanisms of GPI-anchored proteins to the plasma
membrane, for the most part, have been characterized
in nonneuronal cells (Chatterjee and Mayor, 2001).
These studies indicate that GPI-anchored proteins fol-
low a ‘‘canonical’’ secretory pathway: GPI-anchored
proteins are processed in the ER and trafficked
through a population of vesicles in the trans-Golgi
network destined for fusion with the plasma mem-
brane (Brown and Rose, 1992; Mun˜iz and Riezman,
2000; Chatterjee and Mayor, 2001). In neurons, GPI-
anchored proteins are typically targeted to axons
(Harel and Futerman, 1996; Kondoh et al., 1999),
although dendritic localization of some GPI-anchored
proteins has been reported (Faivre-Sarrailh and Rou-
gon, 1993). Insertion of GPI-anchored proteins into
the axonal membrane has been reported to occur
along the axon length and at growth cones, and is
thought to occur in a constitutive, nonregulated man-
ner (Harel and Futerman, 1996). Once on the plasma
membrane, GPI-anchored proteins can be endocy-
tosed, but there is no consensus on the specific endo-
cytic pathway followed (Chatterjee and Mayor, 2001;
Nichols et al., 2001; Fivaz et al., 2002). In principle,
neurons could utilize their unique properties as excit-
able cells to regulate the trafficking of GPI-anchored
molecules, but this has remained largely unexplored.
To determine the cellular mechanisms governing
cell-surface levels of CPG15, we used explant cul-
tures from retina or optic tectum. Such cultures ex-
hibit extensive membrane recycling, including vesicle
exocytosis and endocytosis along the length of grow-
ing axons (Antonov et al., 1999). This membrane cy-
cling occurs in the absence of postsynaptic partners
and likely serves to provide net membrane insertion
in the growing axon and release of neurotransmitter,
which may play a role in synaptogenesis (Antonov
et al., 1999). Consistent with this pattern of mem-
brane trafficking, we find that CPG15 is delivered to
and removed from the axon surface in cultured
explants by KCl depolarization.
To observe delivery of CPG15 directly in explants
and in intact tadpoles, we expressed a fusion protein
of CPG15 and a mutant form of GFP with enhanced
pH sensitivity, the ecliptic pHluorin (Miesenbo¨ck
et al., 1998; Sankaranarayanan and Ryan, 2000).
Experiments with ecliptic pHluorin-CPG15 (EP-
CPG15) demonstrate that CPG15 is delivered to the
axon surface in a depolarization and calcium-depend-
ent manner, whereas GPI-linked YPF does not show
comparable activity-dependent trafficking. In addi-
tion to its presence on the axon surface (Nedivi et al.,
2001), CPG15 colocalized with synaptic vesicle pro-
teins, and by electron microscopy is found in vesicles
and endosomes in presynaptic terminals. Our results
provide evidence in vivo for an activity-dependent
mechanism regulating trafficking of a GPI-anchored
protein in neurons, and suggest that the functional
availability of CPG15 on the axon surface is con-
trolled by neuronal activity. In contrast to the activ-
ity-dependent transcriptional regulation of CPG15
gene expression, the results in this study bring the
regulation of CPG15 function by activity into a dif-
ferent temporal realm. Activity-dependent changes in
transcription or translation would affect the intracel-
lular pool of CPG15 protein, however activity-
dependent delivery to and removal from the plasma
membrane would control the precise cell-surface bio-
availability of the protein.
MATERIALS AND METHODS
Explant Cultures
Stage 53–56 albino Xenopus laevis tadpoles were anesthe-
tized with 0.1% MS222 (Sigma) and both optic nerves were
crushed 4 days prior to retinal explant preparation to
enhance outgrowth from explants. To prepare explants,
eyes were removed from anesthetized tadpoles and placed
in ice-cold HBST buffer (5.8 mM NaCl, 0.6 mM KCl,
0.3 mM CaCl22H2O, 0.83 mM MgSO47H2O, and 5 mM
HEPES, pH 7.7). The pigment epithelium and lens were
removed, and each retina was cut diagonally into eight
pieces, which were plated onto laminin-coated (5% in
HBST) glass coverslips. Culture media (five parts of L-15,
four parts of a solution containing 95 mM NaCl, 1 mM
KCl, 0.6 mM CaCl22H2O, 3.9 mM MgSO47H2O, 4 mM
glutamine, and 9.4 mM HEPES, and one part of fetal calf
serum with 5 ng/mL sodium selenite, 5 mg/mL transferrin,
5 mg/mL insulin, and 1% penicillin streptomycin) was
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added to the explants 2–4 h after plating. Explants were
used 1–2 weeks later.
Tectal explants were prepared 4 days after in vivo whole
brain electroporation to deliver plasmid expressing EP-
CPG15 as previously described (Foa et al., 2001). Brains
were electroporated with 1 mg/mL DNA solution contain-
ing EP-CPG15 expression plasmid (see later). Tecta were
dissected from anesthetized Stage 46–47 albino Xenopus
laevis tadpoles, rinsed in ice-cold HBST buffer, and indi-
vidually plated on poly-L-lysine-coated coverslips (50 mg/
mL in diH2O, Sigma). Media was added after 2–4 h and
explants were used after 1–2 weeks.
For PI-PLC experiments, culture media was exchanged
for PI-PLC (Sigma, 0.4 U/mL in 10 mM Tris buffer, pH 8)
or Tris buffer control solution. In preliminary experiments,
we observed that 1-h exposure to PI-PLC at RT produced a
robust decrease in CPG15 immunoreactivity for this PI-
PLC concentration. For recovery experiments, explants
were rinsed in buffer and then left in the media for different
amounts of time before fixation. In order for the PI-PLC to
be enzymatically active, we used Tris as buffer, since diva-
lent cations are inhibitory at concentrations ranging from 2
to 10 mM (Ikezawa and Taguchi, 1981). Tris buffer treat-
ment for 1 h significantly reduced cell-surface CPG15 to
69% 6 4.7% of control (n ¼ 9 in both groups, Kruskal-
Wallis p < 0.001, Mann-Whitney p ¼ 0.015), but PI-PLC
further decreased CPG15 levels to 26 6 4.8 of control (n ¼
10). This was a significant reduction when compared with
Tris buffer alone or untreated controls (Mann-Whitney p <
0.001). It is possible that the reduction in CPG15 cell-sur-
face levels we observe after Tris treatment alone is due to
reduced Ca++-dependent exocytosis of the protein due to
baseline levels of activity in the explant cultures.
To depolarize the explants, culture media was
exchanged for either a control external solution (1 mM
KCl, 118 mM NaCl, 3 mM CaCl2, 3 mM MgCl2, 5 mM
HEPES, 10 mM glycine, and 10 mM glucose, pH 7.7) or a
high K+ solution (45 mM KCl, 74 mM NaCl, 3 mM CaCl2,
3 mM MgCl2, 5 mM HEPES, 10 mM glycine, and 10 mM
glucose, pH 7.7). In 0 Ca++ experiments, 3 mM CaCl2 was
replaced by 3 mM MgCl2 in the high K
+ solution, and
2 mM EGTA was added to chelate Ca++. Osmolarity was
adjusted to 255 mOsm in all solutions.
Immunocytochemistry
For double labeling of cell-surface CPG15 (non-permeabil-
ized conditions) and filamentous actin (with phalloidin, Mo-
lecular Probes, under permeabilized conditions), cultures
were fixed in 4% paraformaldehyde in 0.1 M phosphate
buffer (PB) for 1 h, and postfixed for 10 min in fresh fixative.
Cultures were rinsed, incubated in 5% normal goat serum
(Vector labs, Burlingame, California) in PB, then in primary
antiserum (polyclonal rabbit anti-CPG15, diluted 1:200 in
PB). Cultures were rinsed and incubated with FITC-conju-
gated secondary antibody diluted 1:200 in PB. Subsequently,
cultures were rinsed in PB, and in 0.3% Triton in PB to per-
meabilize cells, blocked in 5% normal goat serum in 0.3%
Triton in PB, and then incubated with phalloidin conjugated
to RITC (1:800) in 0.03% Triton in PB. Finally, cultures
were rinsed and coverslipped. For double labeling of total
CPG15 (permeabilized conditions) or phalloidin (permeabil-
ized conditions) all incubations were done in 0.03% Triton
in PB. For double labeling of cell-surface and total CPG15,
cell-surface labeling was done first using a RITC-conjugated
secondary antibody, then cultures were permeabilized and
incubations were conducted in Triton-containing solutions,
using a Cy5-conjugated secondary antibody.
EP-CPG15
The sequence encoding EP was subcloned from a pGEX-2T
plasmid obtained from Dr. G. Miesenbo¨ck (Yale Univer-
sity) and inserted either downstream of Xenopus laevis
CPG15 signal sequence (atg gga ctt aag ctg agc ggc aga tat
atc ttt ctg gtc ctc gct gtg cat cta gca tac ctg ctg cag gcg) or
upstream of CPG15’s GPI anchor sequence (ggg gca ccg
gga caa agg ctc cta ttt cca gct ttt ctg cct tta cta atg gtg ttc
ctc tct acc cta ttc atc ttg gta ctt cag tag). Six nucleotide
restriction site sequences were used as linkers: in
EP-CPG15, the signal sequence was flanked by the EcoRI
site (gaa ttc) and acc at its 50 end, and by the StuI site (agg
cct) at its 30 end; EP was flanked by the StuI site at its
50 end, and by the XhoI site (ctc gag) at its 30end; the
remaining CPG15 sequence was flanked by XhoI at its
50 end, and by the XbaI site (tct aga) at its 30 end. In
CPG15-EP, the CPG15 sequence (excluding the GPI
anchor) was flanked by the EcoRI site at its 50 end, and by
the StuI site at its 30 end, EP was flanked by the same sites
as in EP-CPG15, and the GPI anchor was flanked by the
XhoI site at its 50 end, and by the XbaI site at its 30 end. The
fusion construct was subcloned into expression vector
pCS2+ (provided by Dr. N. Schecter, SUNY), and sequenced
for construct verification. The axons expressing EP-CPG15
had comparable responses to depolarizing stimulus as those
expressing CPG15-EP. The YFP-GPI fusion was made
inserting YFP upstream of the GPI anchor of CPG15.
FM1-43 Labeling
For these experiments, retinal explants were grown on
grided coverslips. Prior to FM1-43 labeling, axons were
randomly selected and their grid position noted. Cell culture
media was substituted by external solution containing
4 mM FM1-43 (Molecular Probes). To assess FM1-43
unloading, cultures were loaded with FM1-43 for 15 min in
the presence of 45 mM KCl solution, rinsed in external so-
lution for 2 min, and axons were imaged. Cultures were
depolarized with 45 mM KCl, imaged again after 2 min,
and fixed. After fixation, cultures were processed for
CPG15 immunocytochemistry. Imaged axons were identi-
fied based on their coverslip grid codes.
In Vivo Retinal Stimulation
Retinal ganglion cells were transfected by lipofection.
DNA solution (1 mg/mL) containing EP-CPG15 and
DsRed1-N1 (Clontech) in a 1:1 ratio was mixed (1:3) with
DOTAP lipofectant (Roche) and pressure injected in the
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eye primordium of Stage 20–21 tadpoles (Holt et al., 1990).
Animals were screened for those containing one or a few
doubly transfected axons 4 days later (Stage 45–46).
Double-labeled axons were imaged on a confocal micro-
scope at 2-mm steps in the z-dimension for DsRed1-N1 and
EP-CPG15 labeling. The retina was pressure-injected with
20 mM KA in external solution, and the axon was imaged
again 2 min after the injection. Control animals were unin-
jected or injected with a mixture of 20 mM KA (Sigma) and
1 mM tetrodotoxin (TTX, Alomone Labs).
Image Acquisition and Data Analysis
Immunocytochemistry. Confocal images of the 10 (unless
otherwise indicated) brightest axons of each culture at 0.5-lm
steps were taken. Imaging parameters (laser intensity, bright-
ness, contrast, slit aperture) were set at the beginning of the
imaging session for each secondary antibody to ensure that
images were collected below pixel saturation values. Once
the parameters were set, they were used to image axons of all
treatments within the same experiment. Experimental and
control cultures were imaged alternatively. When RITC,
FITC, or Cy5 were used for double-staining, band-pass filters
were used to avoid emission spectra overlap.
To quantify cell-surface/total CPG15 or cell-surface
CPG15 values, single frames for every secondary antibody
were compiled in a two-image stack. Out of every axon z-
stack, typically one single frame showed the whole axonal
area in focus for both secondary antibodies, and this frame
was selected for quantification. Scion Image and customized
macros written by Dr. Ed Ruthazer (www.cshl.org/labs/cline/
morphometry.html) were used to measure axon area and aver-
age pixel intensity. Axon area was delimited manually fol-
lowing the contour of the axon in the ‘‘total CPG15’’ image,
and brightness was measured as the mean gray value con-
tained in this area. The same contour was used in the ‘‘cell-
surface CPG15’’ image, by changing the frame in the stack.
Mean gray value over background was also measured for ev-
ery frame and subtracted from the respective measurement
over the axon.
EP-CPG15 in Intact Animals. Alternating confocal
images were taken of both EP-CPG15 and DsRed1-N1 at 2-
mm steps. Imaging parameters were adjusted in the first
image for every axon according to expression levels to
avoid pixel saturation. The same parameters were kept for
imaging after treatment. Quantification was carried out as
described earlier for immunolabeled axons. Fluorescence
measurements after treatment were normalized to before
treatment measurements for every axon.
EP-CPG15 in Tectal Explants. Axons in tectal explants
were imaged on a custom-built 2-photon microscope
(Ruthazer and Cline, 2002) at 0.5-mm steps. The excitation
wavelength was 905 nm. Imaging parameters were opti-
mized for every axon before treatment. Quantification was
performed as in immunolabeled axons, on projections of
z-series stacks. The same number of frames was used to
make projections for all the images of every axon. The
mean gray value obtained for every axon after treatment
was normalized to the mean gray value before treatment.
Electron Microscopy
Stage 47 tadpoles were anesthetized with 0.2% MS222. Ice-
cold Steinberg’s solution and fixative (0.6% paraformalde-
hyde, 2% glutaraldehyde, and 0.02% calcium chloride in
0.035 M cacodylate, pH 7.3) were injected intraventricularly
and around the tectal neuropil. Animals were submerged in
cold fixative for 1 h, after which brains were dissected out
and left in fixative overnight at 48C. Brains were then rinsed
in 0.035 M cacodylate (pH 7.3), and postfixed in 1% OsO4 in
0.035 M cacodylate for 1 h at room temperature (RT). This
was followed by three 10-min washes in 0.035 M cacodylate,
and one 10-min wash in diH2O. Brains were dehydrated in
5-min washes in increasing concentrations of ethanol (30, 50,
70, 90, 100%), and washed three times in a 1:1 ethanol–pro-
pylene oxide solution. The tissue was infiltrated in graded
concentrations of Epon-Araldite resin, polymerized, sectioned
with a microtome at 70–90 nm, and collected on Ni grids.
For postembedding immunohistochemistry, ultrathin sec-
tions were hydrated in TBST (20 mM Tris at pH 7.6, 150 mM
NaCl, 1% Tween-20), and incubated overnight with primary
antibody solution diluted in TBST (1:5 for polyclonal rabbit
anti-CPG15, raised in our laboratory (Nedivi et al., 1998),
1:30 for monoclonal anti-SV2, provided by Dr. K. Buckley,
Harvard University). Sections were incubated in secondary
antibody solution diluted in TBST (15-nm gold particles,
Amersham AuroProbeEM; 1:20). Although postembedding
immunogold labeling is characterized by very low detection
efficiency (Polak and Varndell, 1984), we used this method
because it also has low background and provides the most
accurate means to determine subcellular distribution of anti-
gen (Wang et al., 1998). Sections exposed to secondary anti-
body alone showed*7 particles bound per 7.2 mm2 of tissue
area (not shown), in contrast with an estimated number of
*3110 particles per 7.2 mm2 on sections incubated with pri-
mary and secondary antibodies. After drying, sections were
counterstained with 2% uranyl acetate for 15–20 min, washed
three times in diH2O, incubated for 2 min in Reynold’s lead
citrate, washed again in diH2O, and dried. Grids were exam-
ined in an Hitachi H-700 TEM at 75 kV.
RESULTS
Cell-Surface CPG15 is Replenished
Following PI-PLC Treatment
To test the mechanisms by which CPG15 is trafficked
to and from the cell surface, we used explant cultures
of the retina or optic tectum from which projection
neurons extend axons that express CPG15 (Nedivi
et al., 2001). By labeling explants with CPG15 anti-
bodies under nonpermeabilized conditions, we can
identify cell-surface CPG15 (Fig. 1). Cell-surface
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CPG15 is significantly reduced to 27% 6 3.7% of
untreated control values (Kruskal-Wallis p < 0.001,
Mann-Whitney p < 0.001) by 1-h exposure of cul-
tures to bacterial phosphoinositol-specific phospholi-
pase C (PI-PLC), the enzyme which cleaves GPI-
anchored proteins (Ikezawa and Taguchi, 1981). Af-
ter exposure to PI-PLC, explants were returned to
normal culture media and fixed at different time
points over 4 h. Cell-surface levels of CPG15 were
quantified by immunocytochemistry. Cell-surface
CPG15 was replenished to values close to control
within 4 h [73 6 11.1% of control, Mann-Whitney
p ¼ 0.06, Fig. 1(c,d)].
These results demonstrate that changes in CPG15
levels can be quantified by immunocytochemical
assays. They also show that endogenous Xenopus
CPG15 is indeed a GPI-anchored molecule, as pre-
dicted by its sequence (Nedivi et al., 2001), and con-
sistent with other studies which demonstrated that
cell-surface CPG15 expressed in CHO cells is
cleaved by PI-PLC (Naeve et al., 1997). Finally, this
experiment reveals that the protein is trafficked to the
cell surface by mechanisms operating over a time
course similar to those described for other axonal
GPI-anchored molecules (Harel and Futerman, 1996;
Pierre et al., 2001).
CPG15 Trafficking to the Axon Surface
is Regulated by Activity
To test whether depolarization affects cell-surface
levels of CPG15 relative to total CPG15 protein, we
exposed retinal explant cultures to 45 mM KCl for
2 min, after which cultures were fixed and labeled
with CPG15 antibodies first under nonpermeabilized
conditions and then under permeabilized conditions
using different secondary antibodies. A 2-min expo-
sure to 45 mM KCl significantly increased the cell-
surface/total CPG15 ratio to 133% 6 9.1%
of untreated controls [Mann-Whitney p < 0.02,
Fig. 2(a,b)]. To test how longer periods of depolariza-
tion affects cell-surface levels of CPG15, we exposed
retinal explant cultures to 45 mM KCl for 2, 5, or
15 min, after which cultures were fixed and processed
to reveal cell-surface CPG15 and axonal structure
[visualized with rhodamine-phalloidin labeled f-actin,
Fig. 2(c)]. As aforementioned, the 2-min exposure to
45 mM KCl increased cell-surface levels of CPG15
compared to untreated control cultures, however this
effect was transient, since by 5 min CPG15 levels
decreased and by 15 min they were comparable to
baseline. Phalloidin staining indicated that axonal
structure was intact throughout the experiment. These
Figure 1 Cleavage of cell-surface CPG15 by PI-PLC. (a)
Phase-contrast image of a retinal explant. The retinal explant is
in the lower left corner of the panel. The initial segments of axo-
nal bundles and individual axons are observed emanating from
the explant. (b) Higher magnification phase-contrast image of a
single axon growth cone. (c) Recovery of cell-surface CPG15
levels in axons of different retinal explant cultures following PI-
PLC treatment. Cell-surface CPG15 was determined by immu-
nocytochemistry in untreated control cultures, and in PI-PLC-
treated cultures at different times after PI-PLC washout. (d)
Quantification of cell-surface CPG15 normalized to untreated
controls. n ¼ 8–10 axons. *p < 0.05, **p < 0.01, ***p <
0.001, and ‘‘ns’’ ‘‘not significant’’. Values were compared with
controls (symbols immediately above bars) or to PI-PLC treated
axons (top symbols). Scale bar: 50 lm (a), 10 lm (b and c).
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experiments show that depolarization significantly
increases cell-surface CPG15. In addition, longer
periods of depolarization lead to a decrease in cell-
surface CPG15 that may result from activity-depend-
ent endocytosis.
To test whether endocytosis of CPG15 is activity-
dependent, we exposed retinal explant cultures to
45 mM KCl for 2 min and then returned the cultures
to external solution for different periods up to 1 h.
When cultures were depolarized for 2 min and
returned to normal external solution for 13 min, the
cell-surface/total CPG15 ratio was significantly
higher (135 6 6.8%; Kruskal-Wallis p < 0.001,
Mann-Whitney p ¼ 0.032) than controls. Cell-sur-
face/total CPG15 ratios remain elevated for at least
30 min after the 2-min KCl treatment in the absence
of further depolarization, and decrease to basal levels
within 1 h (Fig. 3). These experiments suggest that
reduction of cell-surface CPG15 with continuous
depolarization (Fig. 2) is due to endocytosis of pro-
tein by an activity-dependent mechanism. In the
absence of sustained depolarization by KCl, reduction
of cell-surface CPG15 occurs at a slower rate.
Although a soluble isoform of CPG15 has been
reported in mice (Putz et al., 2005), we have not
observed this form of CPG15 in Xenopus, and it is
unlikely that the decrease in cell-surface CPG15 is
due to cleavage of the GPI-linked CPG15.
CPG15 Exocytosis is Calcium-Dependent
The experiments described so far have the advantage
that they assess the trafficking of endogenous CPG15,
however the conclusions are based on comparisons
between treatments in different cultures, since they
have to be performed on fixed cultures. To observe
CPG15 trafficking directly in living axons, we con-
structed a fusion protein of CPG15 and a highly pH-
sensitive form of green fluorescent protein, ecliptic
pHluorin (Miesenbo¨ck et al., 1998). Fluorescence emis-
sion from ecliptic pHluorin (EP) is decreased at acidic
Figure 2 Depolarization causes a transient increase in cell-surface CPG15. (a) Axons doubly
immunolabeled for cell-surface and total CPG15 under control conditions and after 2 min of
45 mM KCl. (b) Quantification of results exemplified in cell-surface CPG15 is normalized to total
CPG15 levels, and to the control, untreated group. n ¼ 10 axons. *p < 0.05. (c) Axons were dou-
ble-labeled for cell-surface CPG15 and polymerized actin (phalloidin) under control conditions or
at different times after 45 mM KCl exposure. Scale bar: 20 lm (c), 10 lm (a).
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pH. Therefore, EP-CPG15 located in vesicles and other
endocytic compartments which have an acidic pH is
not detected (Miesenbo¨ck et al., 1998; Sankaranar-
ayanan and Ryan, 2000). EP-CPG15 fluorescence
becomes detectable once the protein is delivered to the
cell surface due to the neutral pH of the extracellular
milieu. Therefore, this construct allows us to monitor
cell-surface levels of CPG15 under different treatments
for the same axons and to carry out the experiments
in vivo on axons of transfected cells.
We fused the fluorescent marker EP either down-
stream of the signal sequence of CPG15 (EP-CPG15),
or upstream of the GPI consensus sequence (CPG15-
EP) [Fig. 4(a)]. Both fusion proteins resulted in identi-
cal patterns of labeling in retinal ganglion cell axons,
although the form with EP at the N-terminus of the
mature protein (EP-CPG15) was consistently brighter,
and was therefore used for most of the following
experiments. In all cell types examined, including tec-
tal, telencephalic, and spinal cord neurons, the distribu-
tion of EP-CPG15 at the cell body had a characteristic
ring pattern, similar to the distribution of GP1-anchored
YFP (not shown). This is consistent with the cell-sur-
face distribution expected for GPI-anchored proteins
(Low, 1989) and with that previously observed in
another GPI-anchored protein fused to EP (Miesenbo¨ck
et al., 1998). EP-CPG15 was observed in a characteris-
tic patchy distribution along the axon in explant cul-
tures [Fig. 4(c)] and along the axonal shaft and the
axon arbor in vivo (Fig. 5), comparable to the distribu-
tion of the endogenous cell-surface CPG15 seen by
immunolabeling. The patchy distribution could arise
from delivery at sites of vesicle fusion and restricted
lateral mobility of GPI-anchored proteins because of
their association with lipid rafts (Simons and Toomre,
2000). As previously reported (Miesenbo¨ck et al.,
1998; Sankaranarayanan and Ryan, 2000), exposure of
labeled cells in tectal explants to acidic media (pH ¼
5) resulted in a rapid and dramatic loss of EP-CPG15
fluorescence (not shown). Both this result and the pat-
tern of labeling of EP-CPG15 in the neuronal cell
bodies are consistent with a cell-surface location of the
fluorescent signal.
To test the calcium-dependence of CPG15 deliv-
ery, we used tectal explant cultures expressing
EP-CPG15. We imaged the axons from explants on a
2-photon microscope before and after exposure to
45 mM KCl in the presence or absence of external
calcium. Depolarization by 45 mM KCl for 2 min sig-
nificantly increased EP-CPG15 fluorescence along
the length of the axon (Kruskal-Wallis p < 0.001,
Mann Whitney p ¼ 0.027, Fig. 4), as seen with the
delivery of endogenous CPG15. Activity-dependent
delivery of EP-CPG15 to the axon surface requires
extracellular calcium (Fig. 4). These results indicate
that CPG15 is delivered to the axon surface by a
depolarization-dependent mechanism.
CPG15 Delivery to the Axon Surface
In Vivo is Activity-Dependent
To test the activity-dependent delivery of EP-CPG15
to the axon surface in intact tadpoles, we introduced
the plasmid encoding EP-CPG15 and a second plas-
mid encoding a cytosolic protein, DsRed1-N1 (Baird
et al., 2000) in the eye primordium of Stage 20–21
tadpoles by lipofection. Four days later, at stage 47,
animals were screened to select those with one or few
Figure 3 CPG15 is endocytosed by an activity-dependent
mechanism. (a) Cultures were depolarized in 45-mM KCL
for 2 min (K+ 2m) and washed in external for the periods
indicated. Axons were double-labeled for total CPG15 (left
panels) and cell-surface CPG15 (right panels). (b) Quantifi-
cation of cell-surface/total CPG15 expressed relative to
control group. n ¼ 4–17 axons. *p < 0.05, ‘‘ns’’ ‘‘not sig-
nificant.’’ Scale bar: 20 lm.
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retinal axons in the tectum that expressed both con-
structs. Axons were then imaged on the confocal
microscope for both EP-CPG15 (green) and DsRed1-
N1 (red) signals, before and 2 min after depolariza-
tion of retinal cells by intraocular injection of 20-lM
KA. EP-CPG15 fluorescence increased significantly
to 167%6 14% of untreated controls (Kruskal Wallis
p ¼ 0.002, Mann-Whitney p ¼ 0.001) following KA
injection into the eye, whereas DsRed1-N1 fluores-
cence did not change (107 6 7.2% of untreated con-
trols, Kruskal Wallis p ¼ 0.391). Note that highest
EP-CPG15 fluorescence increases occur at discrete
spots, potentially corresponding to sites of vesicle
exocytosis [Fig. 5(c)]. When EP-CPG15 fluorescence
was normalized to DsRed1-N1 fluorescence, the
average fluorescence was significantly increased to
160% 6 17.2% of control [Kruskal-Wallis p ¼
0.002, Mann-Whitney p ¼ 0.002; Fig. 5(d)].
To test whether the increased EP-CPG15 fluores-
cence following KA-injection was due to increased
action potential activity in retinal ganglion cells, we
coinjected KA with the voltage-dependent sodium
channel blocker tetrodotoxin (TTX). Coinjection of
TTX with KA blocked the increased EP-CPG15 fluo-
rescence (112 6 19.5% of control, Mann Whitney
p ¼ 0.709), and blocked the increased ratio of CPG15
to DsRed1-N1 fluorescence (96 6 15.3% of control,
Mann-Whitney p ¼ 0.823) seen with KA injection
Figure 4 CPG15 exocytosis is Ca++-dependent. (a) Schematic representation of CPG15 struc-
ture and EP/CPG15 fusion proteins. SS stands for signal sequence in the N-terminus, and CPG15
represents the mature protein, without the SS or the GPI anchor sequences. (b) Relative change in
EP-CPG15 compared to initial values with different treatments exemplified in (c). n ¼ 6–10 axons.
(c) EP-CPG15 fluorescence before or 2 min after exposure to external solution, 45 mM K+ or
45 mM K+ in 0 Ca++. Images were pseudocolored according to the color lookup table, where black
is 0 and white is 255. **p < 0.01. Scale bar: 10 lm.
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alone. The results demonstrate directly that depolari-
zation of retinal ganglion cells in vivo causes a rapid
increase in cell-surface CPG15.
Subcellular Distribution of CPG15
We previously reported that CPG15 immunoreactiv-
ity is strong in axon tracts and in the retinotectal neu-
ropil (Nedivi et al., 2001). To determine the subcellu-
lar distribution of CPG15 within axons, we tested
whether CPG15 colocalizes with synaptic vesicle
protein, SV2 in retinal explant cultures. CPG15
immunoreactivity is punctate along the length of the
axon and in growth cones and colocalizes with the
synaptic vesicle protein, SV2 (Fig. 6). SV2 immunor-
eactivity appears as puncta along the length of retinal
axons in explant cultures. Because these cultures lack
Figure 5 Cell-surface EP-CPG15 increases on retinal ganglion cell axons of intact tadpoles after
2-min KA treatment. (a) Schematic representation of the experimental protocol. (b) Projection of a
single retinotectal axon expressing EP-CPG15 imaged on a 2-photon microscope. (c) Images of
DsRed1-N1 and EP-CPG15 fluorescence before and 2 min after specified treatments. (d) Quantifica-
tion of before/after fluorescence ratios for the proteins indicated, or their ratio, normalized to the aver-
age of the untreated control group. n ¼ 7–15 axons. *p < 0.05, **p < 0.01. Scale bar: 20 lm (b, c).
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postsynaptic neurons, the SV2 puncta are not likely
to be bonafide synapses but are more likely sites of
vesicle accumulation. The colocalization of CPG15
and synaptic vesicle protein, together with the obser-
vation (Fig. 2) that a 15-min exposure to 45 mM KCl
results in a transient increase and then removal of
CPG15 from the axon surface, suggests that CPG15
is cycled to and from the axon surface through vesic-
ular compartments in the axon by activity. To test
whether intracellular CPG15 within vesicular com-
partments is delivered to the cell surface with depola-
rizing stimuli, we labeled explants with the lipophilic
dye FM1-43. FM1-43 is a styryl dye that reversibly
binds to membranes, and when bound shows higher
fluorescence than in solution (Cochilla et al., 1999).
FM1-43 has traditionally been used to study dynamic
recycling of synaptic vesicle membrane at synaptic
terminals (Cochilla et al., 1999), where upon brief
depolarization, FM1-43 bound to the plasma mem-
brane is endocytosed into synaptic vesicles. Synaptic
vesicle exocytosis can then be observed as a decrease
in FM1-43 fluorescence following a second exposure
to depolarizing stimuli. However, longer loading pro-
tocols allow the visualization of additional cycling
membrane compartments including endosomes and
their derivative vesicles (Maletic-Savatic et al.,
1999). We exposed retinal explant cultures to FM1-
43 in the presence of 45 mM KCl for 15 min to label
endocytosed compartments of CPG15. This protocol
labeled vesicular structures along the length of retinal
axons with FM1-43 (Fig. 7). After rinsing the
explants with external solution, a 2-min exposure to
45 mM KCl decreased FM1-43 labeling due to vesi-
cle exocytosis. The cell-surface distribution of
CPG15 shows a patchy distribution, parts of which
match the sites of vesicle exocytosis revealed by
FM1-43 destaining [blue stars in Fig. 7(c)]. These
results support the hypothesis that intracellular
CPG15 is localized in vesicles and is trafficked to and
from the axon surface with depolarizing activity.
Figure 6 CPG15 colocalizes with synaptic vesicle protein. CPG15 (a) and SV2 (b) immunoreac-
tivity in retinal explant cultures. Arrows indicate co-distribution of SV2 puncta and dense CPG15
immunoreactivity. Cell-surface CPG15 is relatively diffuse, as seen in Figures 1 and 2. Scale bar:
10 lm.
Figure 7 CPG15 colocalizes with FM1-43 cycling sites. FM1-43 labeling (a) and unloading (b)
in live cultures, and CPG15 immunoreactivity of the same region after fixation (c). Co-distribution
of FM1-43-labeled compartments with CPG15 is shown with blue stars. Note that the tissue is dis-
torted after fixation. Scale bar: 10 lm.
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We used postembedding immunogold labeling and
electron microscopy to determine the ultrastructural
distribution of CPG15 in the retinotectal neuropil of
the optic tectum of tadpoles, where retinal ganglion
cell axons form synapses with optic tectal cell den-
drites (Rybicka and Udin, 1994; Yen et al., 1995). In-
tracellular CPG15 immunoreactivity was associated
with presynaptic terminals, where gold particles were
localized to small clear presynaptic vesicles
[Fig. 8(a)], which also label for the synaptic vesicle
protein SV2 [Fig. 8(d)], dense core vesicles
[Fig. 8(e)], and endosomes [Fig. 8(f)]. As previously
observed in light microscopy studies (Nedivi et al.,
2001), CPG15 immunoreactivity labeled axonal
membrane, characteristic of GPI-anchored proteins
[Fig. 8(g)].
We measured the distribution of gold particles
within five 10 lm 3 10 lm regions of the tectal
neuropil, which is highly enriched with retinotectal
synaptic contacts. These regions had 42 6 5 gold par-
ticles/100 lm2, compared to 0.94 6 0.15 gold par-
ticles/100 lm2 in the cell body region of tectum. For
the organelles that we could identify, half of immuno-
gold particles colocalized with small clear vesicles at
presynaptic terminals. About 12–15% of particles
colocalized each with dense core vesicles and endo-
somes, 10% with perisynaptic membrane, and 10%
with microtubules, within axons or dendrites. About
5% of gold particles in the neuropil were associated
with mitochondria, which we assume represents non-
specific binding. These values are approximate,
because about 30% of all gold particles in the neuro-
pil were associated with subcellular structures, that
we could not identify with confidence.
The intracellular distribution of CPG15 in presyn-
aptic vesicles is consistent with our observations that
the protein is delivered to the axon surface by activ-
ity-dependent mechanisms. Furthermore, the pres-
ence of CPG15 in endosomes supports the idea that
the protein may be removed from the cell surface by
endocytosis.
DISCUSSION
Protein Trafficking Assessed by Ecliptic
pHluorin Fusion Protein Expression
Since the realization that the pH sensitivity of GFP
could be used to track changes in the distribution of
GFP-tagged proteins and the systematic optimization
of GFP to maximize its change in fluorescence under
Figure 8 Ultrastructural localization of CPG15 in tectal neuropil of stage 47 Xenopus laevis tad-
poles. CPG15 (arrows in a–c, and e–h) is found in small clear presynaptic vesicles (a–c) which
resemble synaptic vesicles labeled with synaptic marker SV2 (arrows in d). CPG15 (arrows) is
also found in dense-core vesicles (e), endosomes (f), axon membranes (g), and dendrites (h). Tis-
sue was processed for postembedding immunogold electron microscopy. Scale bar: 0.25 lm.
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different pH conditions (Miesenbock and Rothman,
1997), the resultant GFP variant, ecliptic phluorin
(EP) has been fused to a variety of cell-surface pro-
teins to assess mechanisms of protein trafficking to
and from the plasma membrane (Meyer and Oancea,
2000; Siegel and Isacoff, 2000). Most intracellular
membrane compartments are sufficiently acidic to
quench EP fluorescence. Within the secretory path-
way, membrane compartments become more acidic
as they progress from the endoplasmic reticulum (pH
7.2) through the Golgi (cis-Golgi, pH 6.7; trans-
Golgi, pH 6.0). Secretory granules range from pH 5.7
to 5.0 depending on whether they are in the constitu-
tive or regulated pathway (Kneen et al., 1998; Llopis
et al., 1998; Paroutis et al., 2004). Endocytic com-
partments, through which proteins and lipids can be
removed from and recycled to the plasma membrane,
are rapidly acidified, to achieve pH ranging from 5.9
to 6.0 in endosomes, pH 5.0 to 6.0 in late endosomes,
and about pH 6.5 in recycling endosomes (Maxfield
and McGraw, 2004). Acidification of endosomes
appears to be a general requirement for protein traf-
ficking (Maxfield and McGraw, 2004), and endoso-
mal compartments with neutral pH have not been
observed, unless they are still in contact with the
extracellular medium (Yamashiro and Maxfield,
1984). Indeed, the PH of endosomes in neuronal
axons was measured at pH 5.8–6.2 (Overly and Hol-
lenbeck, 1996).
Originally, EP was fused to synaptic vesicle pro-
teins (Miesenbock and Rothman, 1997) so that the EP
moiety was harbored within the vesicle, where the
acidic pH quenches the fluorescence of the EP. When
the synaptic vesicle fuses with the plasma membrane,
exposure of the EP to the extracellular environment,
which is relatively pH-neutral, permits fluorescence
of the EP. Several labs have made great use of EP or
pHluorin-tagged synaptic vesicle proteins to examine
the mechanisms of redistribution and capture of syn-
aptic vesicle proteins during synaptic transmission
(Fernandez-Alfonso and Ryan, 2004; Li et al., 2005;
Atluri and Ryan, 2006; Granseth et al., 2006). These
same reagents have provided powerful tools for the
examination of synaptic transmission in intact sys-
tems, including the olfactory projections of mice
(Bozza et al., 2004) and Drosophila (Shang et al.,
2007), and are likely to allow a system level analysis
of synaptic activity in relation to complex stimuli and
behavioral paradigms. To generalize, pHluorin-
tagged transmembrane proteins can be very informa-
tive in studies of trafficking from intracellular com-
partments to the plasma membrane. pHluorin-tagged
transferin receptors have been used to visualize mo-
bility of proteins through dynamic endocytotic com-
partments in nonneuronal cells (Merrifield et al.,
2005) and neurons (Park et al., 2006). pHluorins have
also been fused to other vesicular proteins, for
instance, to examine secretion of insulin (Ohara-Imai-
zumi et al., 2002). As another example, ecliptic
pHluorin fusion proteins of neurotransmitter recep-
tors have recently demonstrated the delivery and re-
moval of receptors to and from the cell surface
(Ashby et al., 2004; Bouschet et al., 2005; Jacob
et al., 2005). This study broadens the application of
ecliptic pHluorins to study the mobility of GPI-linked
proteins, and demonstrates that GPI-linked proteins
are harbored in acidic intracellular compartments
prior to activity-dependent delivery to the axon sur-
face. Furthermore, our in vivo results with supereclip-
tic pHluorin-tagged CPG15 demonstrate the wide-
spread distribution of vesicle fusion sites along retinal
axons in the intact animal, in support of previous
work indicating that vesicle fusion in growing axons
is not restricted to obvious synaptic sites (Zakharenko
et al., 1999). It is now clear that protein exocytosis
and endocytosis are key regulatory mechanisms for a
wide variety of signaling events in neurons and non-
neuronal cells (Kennedy and Ehlers, 2006), and that
pHluorins will be valuable reagents in the examina-
tion of regulatory mechanisms controlling dynamics
of protein trafficking in and out of cells.
Activity-Dependent Trafficking of CPG15
We report that the GPI-linked protein CPG15 is traf-
ficked to the axonal membrane by an activity-depend-
ent mechanism both in explant cultures and in intact
animals. This trafficking behavior of CPG15 differs
from that previously reported for other GPI-anchored
proteins in that it cycles to and from the axon surface
by a calcium-dependent mechanism, and an intracel-
lular pool of CPG15 in axons is associated with
vesicles and endosomes. Cell-surface delivery of
CPG15 to retinotectal axons occurs all along the axon
length, consistent with previous studies showing that
calcium-dependent vesicle cycling can occur all
along growing axons, independently of apposition to
postsynaptic structures (Matteoli et al., 1992; Dai and
Peng, 1996; Antonov et al., 1999). Therefore, traf-
ficking of CPG15 in explant cultures appears to take
advantage of exocytotic machinery (Zakharenko
et al., 1999) but is not necessarily limited to bonafide
synaptic sites. Synaptic vesicles may accumulate
CPG15 from the axon surface by virtue of the high
degree of local membrane cycling at synaptic sites
(Lin and Scheller, 2000).
Although CPG15 continuously cycles to and from
the plasma membrane with activity, we were able to
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detect a net increase of about 30% in the cell-surface/
total ratio of CPG15 followed by a decrease during
sustained depolarization. While endocytotic mecha-
nisms of GPI-anchored proteins in nonneuronal cells
are still a matter of debate (Chatterjee and Mayor,
2001), our results suggest that neurons take advantage
of their excitable properties to regulate endocytosis
of CPG15 in an activity-dependent manner. Consider-
ing that we observe both delivery and removal of
CPG15 from the plasma membrane with depolariza-
tion, our observation suggests that the initial balance
of exocytosis to endocytosis is shifted toward net
exocytosis with depolarization. Although blocking
endocytosis might be expected to result in an increase
in cell-surface CPG15, other studies have demon-
strated that blocking endocytosis can also affect
delivery of protein to the plasma membrane, possibly
by interfering with trafficking through recycling
endosomes.
Endocytosis has recently become appreciated as a
complex means to control cell-surface expression of
plasma membrane proteins (Kennedy and Ehlers,
2006). In axon guidance, L1-mediated adhesion is
regulated by endocytotic control of cell-surface levels
of L1 (Long et al., 2001). Recent data indicate that
activation of guidance molecules, such as semaphorin
receptors, can lead to a coordinated endocytosis of
the receptor, neuropilin, along with the associated
L1-adhesion molecule (Castellani et al., 2004; Piper
et al., 2005). This enables spatio-temporal control of
response to axon guidance cues along with a decrease
in adhesion necessary for changes in growth cone
behavior. Cell-surface levels of key regulatory pro-
teins can be replenished by mechanisms requiring
protein synthesis (Piper et al., 2005; Piper et al.,
2006) or local delivery from recycling endosomes
(Park et al., 2006).
Recovery of Cell-Surface CPG15
After PI-PLC
We have shown that CPG15 is found on the surface
of axons in Xenopus neurons where it can be cleaved
by exogenous PI-PLC, two features that are diagnos-
tic for GPI-anchored proteins (Faivre-Sarrailh and
Rougon, 1997; Chatterjee and Mayor, 2001). Cell-
surface levels of CPG15 are replenished following
PI-PLC application over a time course of hours, more
quickly than the rates reported for other GPI-anch-
ored molecules in axons (Harel and Futerman, 1996;
Pierre et al., 2001) and in nonneuronal cells (Lisanti
et al., 1990). The more rapid rate of recovery of
cell-surface CPG15 compared to other axonal GPI-
anchored proteins (Harel and Futerman, 1996;
Pierre et al., 2001) could reflect a contribution by the
rapid activity-dependent component of delivery
due to basal levels of electrical activity in the explant
cultures.
Functional Implications of
Activity-Dependent CPG15 Trafficking
The data indicate that cell-surface levels of CPG15
can be quickly increased coincident with the same
axonal activity that would result in synaptic transmis-
sion. A recent study suggests that a netrin, a classic
guidance molecule, and brain-derived neurotrophic
factor (BDNF) can depolarize axonal growth cones
and induce calcium influx through activation of tran-
sient receptor potential (TRP) channels (Wang and
Poo, 2005). The source and magnitude of depolariza-
tion of axons in vivo that might regulate cell-surface
levels of CPG15 are not yet known, however local
depolarization, for instance by BDNF, or action
potentials triggered by visual activity are reasonable
candidates. BDNF is known to affect Xenopus retinal
axon structural plasticity (Hu et al., 2005), and it is
possible that BDNF and CPG15 may have coopera-
tive effects in retinotectal development. The lifetime
of CPG15 on the axon surface is also controlled by
activity, such that maintained levels of activity reduce
surface levels of CPG15 due to endocytosis.
What might be the functional consequences of ac-
tivity dependent control of cell-surface CPG15 lev-
els? Our previous studies have shown that CPG15
expression increases the elaboration of both tectal
cell dendritic arbors and retinal ganglion cell axon
arbors and also increases the strength of retinotectal
synaptic transmission. All these functions of CPG15
occur in a noncell autonomous manner and require
that the protein be tethered to the cell surface by the
GPI anchor. These data, together with the predomi-
nant localization of CPG15 in axons, suggest that
CPG15 functions as a signaling molecule with neuro-
trophic activity. These new results, demonstrating a
rapid, activity-dependent trafficking of CPG15 to the
axon surface, suggest that CPG15 may exert its neu-
rotrophic effects under strict spatiotemporal control,
so that enhanced synaptic function can be coordinated
with pre- and postsynaptic structural plasticity.
Many GPI-anchored proteins play a prominent
role in axon guidance (Walsh and Doherty, 1991;
Faivre-Sarrailh and Rougon, 1997; Knoll and
Drescher, 2002) and some are involved in synaptic
plasticity (Gao et al., 1998; Murai et al., 2002). It is
interesting to note that GPI-anchored proteins are
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sorted into lipid microdomains called rafts (Brown
and Rose, 1992; Simons and Toomre, 2000), which
are thought to be organized functional signal trans-
duction complexes. This suggests that GPI-linked
proteins and associated signaling complexes may be
dynamically regulated within the axon membrane.
The observation that F3/contactin localizes to puta-
tive synaptic boutons at the light microscope level
(Pierre et al., 2001) suggests that its distribution
within axons may also be governed by activity. It
would be interesting to test whether the spatiotempo-
ral distribution of other GPI-anchored proteins on the
neuronal surface is also tightly regulated by activity.
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